Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry

Journal of Stroke and Cerebrovascular Diseases

Volumn 19, Issue 3, 2010, Pages 190-197

  Uchiyama, Shinichiro ^a   Shibata, Yoshisato ^b   Hirabayashi, Takayuki ^c   Mihara, Ban ^d   Hamashige, Naohisa ^e   Kitagawa, Kazuo ^f   Goto, Shinya ^g   Origasa, Hideki ^h   Shimada, Kazuyuki ⁱ   Kobayashi, Hiroyuki ^g   Isozaki, Mitsuhiro ^g   Ikeda, Yasuo ^j  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Miyazaki Medical Association Hospital   (Japan)

^c SUNAGAWA CITY MEDICAL CENTER   (Japan)

^d Mihara Memorial Hospital   (Japan)

^e Chikamori Hospital   (Japan)

^f OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^g TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF TOYAMA   (Japan)

ⁱ JICHI MEDICAL UNIVERSITY   (Japan)

^j KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

atrial fibrillation; myocardial infarction; Registry; Risk factor; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; TICLOPIDINE; WARFARIN;

AGED; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; REGISTER; RISK FACTOR; STROKE; THROMBOSIS;

AGED; ATRIAL FIBRILLATION; CARDIOMYOPATHY, DILATED; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS; STROKE; THROMBOSIS;

EID: 77953222347     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2009.04.004     Document Type: Article

References (43)

1. J-TRACE. Available from: URL:http://www.j-trace.com.
2. Yamazaki T., Goto S., Shigematsu H., et al., for the REACH Registry Investigators. Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Circ J 71 (2007) 995-1003
3. Kimura K. Statistics of atrial fibrillation stratified by age and gender. In: Kobayashi S. (Ed). The Japanese standard stroke registry 2005 [in Japanese] (2006), Nakayama-shoten, Tokyo 50-51
4. World Health Organization. The world health report 2002. Available from: URL:http://www.who.int/whr/2002/en.
5. Statistics and Information Department, Ministry of Health, Labor, and Welfare, Japanese Government. Abridged life tables for Japan 2005. Available from: URL:http://www.mhlw.go.jp.
6. Kimura K., Kazui S., Minematsu K., et al., for the Japan Multicenter Stroke Investigator's Collaboration (J-MUSIC). Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan: A hospital-based prospective registration study. Cerebrovasc Dis 18 (2004) 47-56
7. Origasa H., Goto S., Uchiyama S., et al., on behalf of the J-TRACE Investigators. The Japan thrombosis registry for atrial fibrillation, coronary or cerebrovascular events (J-TRACE): A nation-wide, prospective large cohort study; the study design. Circ J 72 (2008) 991-997
8. Katsuki S., Hirota Y., Akizone T., et al. Epidemiological study on cerebrovascular diseases in Hisayama, Kyushu Island, Japan, I: With particular reference to cardiovascular status. Jpn Heart J 127 (1964) 12-36
9. Yusuf S., Reddy S., Ounpuu S., et al. Global burden of cardiovascular diseases, part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104 (2001) 2746-2753
10. Yusuf S., Reddy S., Ounpuu S., et al. Global burden of cardiovascular diseases, part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and preventive strategies. Circulation 104 (2001) 2855-2864
11. Multinational monitoring of trends and determinants in cardiovascular disease (MONICA project). Available from: URL:http://www.ktl.fi/monica.
12. Fox C.S., Evans J.C., Larson M.G., et al. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: The Framingham heart study. Circulation 110 (2004) 522-527
13. Steg P.G., Bhatt D.L., Wilson P.W., et al., for the REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297 (2007) 1197-1206
14. Brand F.N., Abbott R.D., Kannel W.B., et al. Characteristics and prognosis of lone atrial fibrillation: 30-Year follow-up in the Framingham study. JAMA 254 (1985) 3449-3453
15. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation: A major contributor to stroke in the elderly; the Framingham study. Arch Intern Med 147 (1987) 1561-1564
16. Heeringa J., van der Kuip D.A., Hofman A., et al. Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J 27 (2006) 949-953
17. Kannel W.B. Fifty years of Framingham study contributions to understanding hypertension. J Hum Hypertens 14 (2000) 83-90
18. Stamler J., Stamler R., and Neaton J.D. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 153 (1993) 598-615
19. MacMahon S., Peto R., Culter J., et al. Blood pressure, stroke, and coronary heart disease, part 1: Prolonged differences in blood pressure; prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
20. Okayama A., Kadowaki T., Okamura T., et al., for the NIPPON DATA 80 Research Group. Age-specific effects of systolic and diastolic blood pressure on mortality due to cardiovascular diseases among Japanese men. J Hypertens 24 (2006) 459-462
21. Stamler J., Vaccaro O., Neaton J.D., et al. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16 (1993) 434-444
22. Fujishima M., Kiyohara Y., Kato I., et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama study. Diabetes 45 (1996) S14-S16 (suppl)
23. Matsuzaki M., Kita T., Mabuchi H., et al., for the J-LIT Study Group. Japan lipid intervention trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 66 (2002) 1087-1095
24. Horiuchi H., Kita T., Mabuchi H., et al., for the J-LIT Study Group. Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: A subanalysis of the Japan lipid intervention trial. J Am Geriatr Soc 52 (2004) 1981-1987
25. Nakamura Y., Okamura T., Tamaki S., et al., for the NIPPON DATA 80 Research Group. Egg consumption, serum cholesterol, and cause-specific and all-cause mortality: The national integrated project for prospective observation of non-communicable disease and its trends in the aged, 1980 (NIPPON DATA 80). Am J Clin Nutr 80 (2004) 58-63
26. Nakamura H., Arakawa K., Itakura H., et al., for the MEGA Study Group. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA study): A prospective randomized controlled trial. Lancet 368 (2006) 1155-1163
27. Wolf P.A., D'Agostino R.B., Kannel W.B., et al. Cigarette smoking as a risk factor for stroke: The Framingham study. JAMA 259 (1988) 1025-1029
28. Kiyohara Y., Ueda K., and Fujishima M. Smoking and cardiovascular disease in the general population in Japan. J Hypertens Suppl 8 (1990) S9-S15
29. Mannami T., Iso H., Baba S., et al. Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: The JPHC study cohort I. Stroke 35 (2004) 1248-1253
30. Frost L., Hune L.J., and Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish diet, cancer, and health study. Am J Med 118 (2005) 489-495
31. Murphy N.F., MacIntyre K., Stewart S., et al. Long-term cardiovascular consequences of obesity: 20-Year follow-up of more than 15,000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 27 (2006) 96-106
32. Dublin S., French B., Glazer N.L., et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med 166 (2006) 2322-2328
33. Wang T.J., Parise H., Levy D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004) 2471-2477
34. Djoussé L., Levy D., Benjamin E.J., et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham study. Am J Cardiol 93 (2004) 710-713
35. Frost L., and Vestergaard P. Alcohol and risk of atrial fibrillation or flutter: A cohort study. Arch Intern Med 164 (2004) 1993-1998
36. Mukamal K.J., Tolstrup J.S., Friberg J., et al. Alcohol consumption and risk of atrial fibrillation in men and women: The Copenhagen city heart study. Circulation 112 (2005) 1736-1742
37. Mukamal K.J., Psaty B.M., Rautaharju P.M., et al. Alcohol consumption and risk of prognosis of atrial fibrillation among older adults: The cardiovascular health study. Am Heart J 153 (2007) 260-266
38. Goldstein L.B., Adams R., Alberts M.J., et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association stroke council; cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group; the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 1583-1633
39. McCormick D., Gurwitz J.H., Goldberg R.J., et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 161 (2001) 2458-2463
40. Tapson V.F., Hyers T.M., Waldo A.L., et al., for NABOR (National Anticoagulation Benchmark and Outcomes Report) Steering Committee. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med 165 (2005) 1458-1464
41. Uchiyama S., Hori M., and Nakamura Y. A nationwide survey on present status of antithrombotic therapy in our country: The antithrombotic therapy study group. [in Japanese]. Jpn J Thromb Hemost 14 (2003) 458 (abstr)
42. Sato H., Ishikawa K., Kitabatake A., et al., on behalf of the Japan Atrial Fibrillation and Stroke Trial (JAST) Group. Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan atrial fibrillation stroke trial. Stroke 37 (2006) 447-451
43. DeWilde S., Carey I.M., Emmas C., et al. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 92 (2006) 1064-1070